A new study reveals a number of different factors, including smoking, age, education levels, sex, handedness, and family medical history, which can have an impact on reaction time.
A new large-scale study links smoking and cardiovascular disease to an increased risk of developing dementia. Smoking and cardiovascular disease impact memory and learning throughout adulthood, starting at age 18. Researchers say smoking has the biggest impact on cognitive function in women, while cardiovascular disease has a more detrimental impact on cognition in men.
Stress, boredom, and more free time may account for the rise in cigarette consumption in smokers during the COVID pandemic.
Between 60-90% of people with schizophrenia smoke, compared to between 15-24% of the general population. A new study found 40% of those with schizophrenia stopped smoking traditional cigarettes after 12 weeks of switching to e-cigarettes. Researchers also reported a significant number of participants sustained their reduction in smoking or completely stopped smoking at the end of the 12-week study.
Quitting smoking can help reduce depression and anxiety within weeks, a new study reports.
Smokers with a higher dependency on tobacco had a greater probability of reporting symptoms of depression.
Mixing traditional cigarettes with vaping products is as detrimental to health as smoking cigarettes alone, a new study reports.
Those who consider themselves to be light smokers, in that they smoke between one to four cigarettes a day, meet the criteria for nicotine addiction.
Fifty-seven social and behavioral factors have been identified as the top contributors to increased mortality. Of those, smoking, divorce, and alcohol abuse are the top factors that are associated with a reduced lifespan.
Age, sex, and gender influence the organization of the brain's opioid system. Findings shed light on why there are significant differences between the opioid system on an individual level, and why some are more prone to developing opioid-linked pathologies than others.
Smoking increases the gene expression of ACE2, a protein that binds to SARS-CoV-2, increasing the risk of coronavirus infection. Findings suggest long-term smokers could have an increase of ACE2 in the lungs, leading to higher rates of morbidity in COVID-19 patients.
Smoking remodels the gene expression of lung cells so that the ACE2 gene is more highly expressed in goblet cells. The effects of smoking on ACE2 pulmonary expression indicates an increase in the overall entry points for coronavirus and increases the risk for viral binding and entry of COVID-19 into the lungs.
